Kirkland & Ellis represented the sole overall coordinator and placing agent, China International Capital Corporation Hong Kong Securities Limited, in the transaction. ImmuneOnco Biopharmaceuticals (Shanghai) Inc....
ImmuneOnco Biopharmaceuticals’ HK$234 Million Shares Placement
Super Hi’s IPO
Kirkland & Ellis represented Super Hi International Holding Ltd. in the offering. Super Hi International Holding Ltd. (“Super Hi”), the overseas operator of Chinese hot pot...
Kelun-Biotech Biopharmaceutical’s H-Share Placing
Kirkland & Ellis represented the placing agents in the deal. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd (“Kelun-Biotech”) announced it completed the H-share placing (the “H-Share Placing”). Kelun-Biotech...
ImmuneOnco Biopharmaceuticals’ HK$319 Million IPO
Cooley and JunHe advised ImmuneOnco Biopharmaceuticals on the offering, and Kirkland & Ellis and Jingtian & Gongcheng advised the joint sponsors and underwriters. ImmuneOnco Biopharmaceuticals announced...
Super Hi’s Spin-off and Separate Listing
Kirkland & Ellis advised on Hong Kong law, Jingtian & Gongcheng advised on PRC law, Conyers Dill & Pearman advised on Cayman Islands law, Drew &...
Yunkang Group Limited’s $140 Million Hong Kong Listing
Kirkland & Ellis and Zhong Lun advised Yunkang Group Limited on the deal. Herbert Smith Freehills advised CMB International Capital Limited and SPDB International Capital Limited....
Recbio Technology Co., Ltd.’s US$98 Million Initial Public Offering
Kirkland & Ellis advised Jiangsu Recbio Technology Co., Ltd., while Clifford Chance has advised the joint sponsors and underwriters involved in the deal. Recbio Technology Co.,...
CANbridge Pharmaceuticals Inc.’s HK$604 Million IPO
Harneys, alongside Davis Polk & Wardwell and King & Wood Mallesons, acted as Cayman Islands counsel to CANbridge Pharmaceuticals Inc. Kirkland & Ellis and Tian Yuan...
Airdoc Technology’s $215 Million Initial Public Offering
Kirkland & Ellis advised Beijing Airdoc Technology Co., Ltd on the offering. Airdoc, raised approximately $215 million in the IPO, received strong endorsement from blue-chip investors...
Clover Biopharmaceuticals’ US$257.8 Million Hong Kong Initial Public Offering
Skadden advised Goldman Sachs (Asia) L.L.C., China International Capital Corporation Hong Kong Securities Limited and Credit Suisse (Hong Kong) Limited as lead underwriters on the IPO....
Magnum Opus’ Business Combination with Forbes
Kirkland & Ellis represented Magnum Opus, while Cadwalader, Wickersham & Taft represented Forbes. King & Spalding advised JonesTrading in the transaction. Forbes Global Media Holdings Inc.,...
Joy Spreader Interactive Technology Ltd’s IPO
Sidley Austin LLP and Tian Yuan advised Joy Spreader Interactive Technology. Ltd on the deal. Joy Spreader Interactive Technology. Ltd (HKEX:6988) (Joy Spreader) acted as Hong...